Literature DB >> 26503152

Modern drug delivery systems for targeting the posterior segment of the eye.

Catalina A Peptu, Marcel Popa1, Corina Savin, Radu F Popa, Lacramioara Ochiuz.   

Abstract

Some of the most dangerous diseases of the eye are related to the posterior segment. Diseases such as age-related macular degeneration, cytomegalovirus retinitis, diabetic retinopathy, posterior uveitis and retinitis pigmentosa are difficult to treat using classical methods because of the many internal barriers of the eye which affect the drug efficiency. In this review, we will summarize the main research directions in the field of medicamentous treatment of posterior eye disorders belonging to the controlled drug delivery concept. The review is starting with the most important knowledge regarding anatomy and pathology of the posterior segment of the eye and is continuing with the current treatment methods of the eye posterior segment illnesses and drawbacks of these methods, the drugs administration pathways to the posterior segment of the eye. The last three sections present the state of the art regarding the latest discoveries including the commercial products in the modern drug delivery systems; the main classes of materials treated in the present review are implants, hydrogels and nano- microparticulate systems.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26503152     DOI: 10.2174/1381612821666151027151847

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

1.  Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS.

Authors:  Rohit Bisht; Abhirup Mandal; Ilva D Rupenthal; Ashim K Mitra
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

2.  Controllable continuous sub-tenon drug delivery of dexamethasone disodium phosphate to ocular posterior segment in rabbit.

Authors:  Xuetao Huang; Shaogang Liu; Yezhen Yang; Yiqin Duan; Ding Lin
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Long-acting protein drugs for the treatment of ocular diseases.

Authors:  Joy G Ghosh; Andrew A Nguyen; Chad E Bigelow; Stephen Poor; Yubin Qiu; Nalini Rangaswamy; Richard Ornberg; Brittany Jackson; Howard Mak; Tucker Ezell; Vania Kenanova; Elisa de la Cruz; Ana Carrion; Bijan Etemad-Gilbertson; Roxana Garcia Caro; Kan Zhu; Vinney George; Jirong Bai; Radhika Sharma-Nahar; Siyuan Shen; Yiqin Wang; Kulandayan K Subramanian; Elizabeth Fassbender; Michael Maker; Shawn Hanks; Joanna Vrouvlianis; Barrett Leehy; Debby Long; Melissa Prentiss; Viral Kansara; Bruce Jaffee; Thaddeus P Dryja; Michael Roguska
Journal:  Nat Commun       Date:  2017-03-23       Impact factor: 14.919

Review 4.  Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets.

Authors:  Shen Nian; Amy C Y Lo; Yajing Mi; Kai Ren; Di Yang
Journal:  Eye Vis (Lond)       Date:  2021-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.